US45104G1040 - ADR

Overall **IBN** gets a fundamental rating of **4** out of 10. We evaluated **IBN** against 410 industry peers in the **Banks** industry. While **IBN** is still in line with the averages on profitability rating, there are concerns on its financial health. **IBN** is valued quite expensively, but it does show have an excellent growth rating.

In the past year **IBN** was profitable.

In the past 5 years **IBN** has always been profitable.

Of the past 5 years **IBN** 4 years had a positive operating cash flow.

Looking at the **Return On Assets**, with a value of **1.87%**, **IBN** belongs to the top of the industry, outperforming **94.88%** of the companies in the same industry.

The **Return On Equity** of **IBN** (**17.28%**) is better than **95.37%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 1.87% | ||

ROE | 17.28% | ||

ROIC | N/A |

ROA(3y)1.68%

ROA(5y)1.38%

ROE(3y)15.65%

ROE(5y)13.28%

ROIC(3y)N/A

ROIC(5y)N/A

The **Profit Margin** of **IBN** (**27.33%**) is better than **71.46%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | 27.33% | ||

GM | N/A |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y20.83%

PM growth 5Y42.71%

GM growth 3YN/A

GM growth 5YN/A

The number of shares outstanding for **IBN** has been increased compared to 5 years ago.

The **Debt to FCF ratio** of **IBN** (**1.34**) is better than **71.46%** of its industry peers.

A Debt/Equity ratio of **0.81** indicates that **IBN** is somewhat dependend on debt financing.

Even though the debt/equity ratio score it not favorable for **IBN**, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.81 | ||

Debt/FCF | 1.34 | ||

Altman-Z | N/A |

ROIC/WACCN/A

WACC8.54%

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | N/A | ||

Quick Ratio | N/A |

The **Earnings Per Share** has grown by an impressive **27.68%** over the past year.

Measured over the past years, **IBN** shows a very strong growth in **Earnings Per Share**. The EPS has been growing by **61.93%** on average per year.

Looking at the last year, **IBN** shows a quite strong growth in **Revenue**. The Revenue has grown by **19.39%** in the last year.

EPS 1Y (TTM)27.68%

EPS 3Y34.49%

EPS 5Y61.93%

EPS Q2Q%16.84%

Revenue 1Y (TTM)19.39%

Revenue growth 3Y10.91%

Revenue growth 5Y11.94%

Sales Q2Q%-51.59%

The **Earnings Per Share** is expected to grow by **12.82%** on average over the next years. This is quite good.

EPS Next Y11.6%

EPS Next 2Y13.06%

EPS Next 3Y12.82%

EPS Next 5YN/A

Revenue Next Year14.13%

Revenue Next 2Y15.16%

Revenue Next 3Y16.1%

Revenue Next 5YN/A

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

With a **Price/Earnings** ratio of **19.28**, **IBN** is valued on the expensive side.

Based on the **Price/Earnings** ratio, **IBN** is valued more expensive than 83.66% of the companies in the same industry.

The average S&P500 **Price/Earnings** ratio is at **28.73**. **IBN** is valued slightly cheaper when compared to this.

The **Price/Forward Earnings** ratio is **17.33**, which indicates a rather expensive current valuation of **IBN**.

When comparing the **Price/Forward Earnings** ratio of **IBN** to the average of the S&P500 Index (**20.21**), we can say **IBN** is valued inline with the index average.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 19.28 | ||

Fwd PE | 17.33 |

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 5.14 | ||

EV/EBITDA | N/A |

The **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

PEG (NY)1.66

PEG (5Y)0.31

EPS Next 2Y13.06%

EPS Next 3Y12.82%

Compared to an average industry **Dividend Yield** of **3.93**, **IBN**'s dividend is way lower than its industry peers. On top of this 85.12% of the companies listed in the same industry pay a better dividend than **IBN**!

With a **Dividend Yield** of **0.90**, **IBN** pays less dividend than the S&P500 average, which is at **2.39**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.9% |

The dividend of **IBN** is nicely growing with an annual growth rate of **34.51%**!

Dividend Growth(5Y)34.51%

Div Incr Years0

Div Non Decr Years0

The dividend of **IBN** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP12.65%

EPS Next 2Y13.06%

EPS Next 3Y12.82%

**ICICI BANK LTD-SPON ADR**

NYSE:IBN (6/18/2024, 7:04:00 PM)

After market: 26.94 -0.05 (-0.19%)**26.99**

**+0.64 (+2.43%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap94.89B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.9% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 19.28 | ||

Fwd PE | 17.33 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)1.66

PEG (5Y)0.31

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 1.87% | ||

ROE | 17.28% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | 27.33% | ||

GM | N/A | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.07

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.81 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | N/A | ||

Quick Ratio | N/A | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)27.68%

EPS 3Y34.49%

EPS 5Y

EPS Q2Q%

EPS Next Y11.6%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)19.39%

Revenue growth 3Y10.91%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y